Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1Giuseppe Giaccone, David H. Johnson, Roy S. Herbst et al.|Journal of Clinical Oncology|2004Cited by 1.7k
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study GroupFrank V. Fossella, Chandra P. Belani, Jose R. Pereira et al.|Journal of Clinical Oncology|2003Cited by 943
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation TrialU. Gatzemeier, Joachim von Pawel, A Płużańska et al.|Journal of Clinical Oncology|2007Cited by 879
Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline TreatmentKathy S. Albain, Joyce O’Shaughnessy, Lorinda Simms et al.|Journal of Clinical Oncology|2008Cited by 422
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)U. Gatzemeier, Joachim von Pawel, A Płużańska et al.|Journal of Clinical Oncology|2004Cited by 300